Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazopyrazine inhibitors of Bruton's tyrosine kinase

Imidazopyrazine inhibitors of Bruton's tyrosine kinase

US Patent 11110088 · Granted Sep 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2025
Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]2023
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2023
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor2023
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor2021
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2021
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]2021
4-imidazopyridazin-1-yl-benzamides as Btk inhibitors2021
Imidazopyrazine inhibitors of Bruton's tyrosine kinase2020
Imidazopyrazine inhibitors of Bruton's tyrosine kinase2020
Imidazopyrazine inhibitors of Bruton's tyrosine kinase2020
Imidazopyrazine inhibitors of Bruton's tyrosine kinase2020